Clinical Trials

We are always on the lookout for participants for our clinical trials, in the areas of Type 2 Diabetes, Insomnia, Obesity and Anxiety. Please click on the relative links below to apply and find out more information.

Clincial Trials | Neurovalens

Post-Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder (PTSD) is a common psychiatric disorder that develops following exposure to a traumatic event and is associated with several health consequences, such as acute stress and anxiety disorders and sleep disturbances or insomnia. We are actively recruiting for a Clinical Trial that uses the Modius Spero Trial Device which is indicated to manage PTSD symptoms through the action of Cranial Electrotherapy Stimulation being delivered to the head in a non-invasive way that has been shown to be both safe and effective across multiple populations.

Primary Outcomes:
Reduce stress & improve sleep

Locations:
Remote US Trial,
UCSD

Duration:
12 Weeks

Status:
Actively Recruiting

Apply Now

Anxiety

We are actively recruiting for a fully remote (participants can fully participate from home) Clinical Trial to evaluate the Efficacy of Electrical Vestibular Stimulation (VeNS), for The Management of Anxiety.

Primary Outcomes:
Reduced stress & anxiety

Locations:
Belfast,
Northern Ireland

Duration:
4 Weeks

Status:
Actively Recruiting

Apply Now

Adults with Type 2 Diabetes

Electrical vestibular nerve stimulation (VeNS) compared to sham control as a means of improving glycemic control in adults with Type 2 Diabetes mellitus. In a 16-week study with type 2 diabetic patients, our Vestal DM technology demonstrated a 0.4% reduction in HbA1c.

Primary Outcomes:
HbA1c reduction

Location:
ActivMed Research,
Methuen,
Massachusetts

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
Adult Medicine of Lake County,
Mount Dora,
Florida

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
ActivMed Research,
Portsmouth,
New Hampshire

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
Billings Clinic,
Billings,
Montana

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
Charlottesville Medical Research,
Virginia

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Locations:
The Exercise and Physical Activity Resource Center (EPARC),
San Diego

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Locations:
Complete Health Partners,
Nashville,
Tennessee

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
NCMR Medical Research Centre,
Sacramento

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
Ichan School of Medicine,
Mount Sinai,
New York

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
Oviedo Medical Research Centre,
Florida

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
RGV Endocrine Center,
McAllen,
Texas

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
South Florida Research Organisation,
Miami,
Florida

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Locations:
Department of Nutrition Sciences,
University of Alabama,
Birmingham,
Alabama

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Primary Outcomes:
HbA1c reduction

Location:
University College Dublin,
Ireland

Duration:
24 Weeks

Status:
Actively Recruiting

Apply Now

Clinical Papers

Modulation of sleep using electrical vestibular nerve stimulation prior to sleep onset View Clincial Paper
Electrical vestibular nerve stimulation (VeNS) View Clincial Paper
The efficacy of cranial electrotherapy stimulation (CES) for the relief of anxiety and depression among polysubstance abusers in chemical dependency treatment View Clincial Paper
Anti-diabetic effect of vestibular stimulation is mediated via AMP-activated T protein kinase View Clincial Paper
Electrical vestibular nerve stimulation as an adjunctive therapy in the management of type 2 diabetes View Clincial Paper
Investigation of effects of galvanic vestibular stimulationon patients With type 2 diabetes View Clincial Paper
Vestibular stimulation: A simple but effective intervention in diabetes care View Clincial Paper
Can vestibular stimulation be used to treat obesity? View Clincial Paper
Modulation of body mass composition using vestibular nerve stimulation View Clincial Paper
The influence of vestibular stimulation on metabolism and body composition View Clincial Paper
Cranial Electrotherapy Stimulation as a Treatment for Anxiety in Chemically Dependent Persons View Clincial Paper